-
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Rating of "Moderate Buy" from Brokerages
ソース: Buzz FX / 16 3 2025 01:16:17 America/Chicago
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 16, 2025 Share Link copied to clipboard. Remove Ads Sangamo Therapeutics, Inc.
Read more...